National vaccine advisory committee issues recommendations to strengthen supply of routine vaccines

December 16, 2003

In an effort to enhance the supply of necessary childhood vaccines without the shortages seen in recent years, the National Vaccine Advisory Committee (NVAC) has issued a list of recommendations that are published in a special communication in the December 17 issue of The Journal of the American Medical Association (JAMA).

The NVAC was chartered in 1988 to advise and make recommendations to the Director of the National Vaccine Program and the Assistant Secretary for Health at the Department of Health and Human Services on matters related to the prevention of infectious diseases through immunization and the prevention of adverse reactions to vaccines. The NVAC is composed of 15 members from public and private organizations representing vaccine manufacturers, physicians, parents, and state and local health agencies.

"Beginning in late 2000, significant unprecedented and unanticipated shortages of routinely administered vaccines against 8 of 11 vaccine-preventable childhood infectious diseases occurred in the United States," according to background information provided by the Committee's report. "Affected vaccines included diphtheria and tetanus toxoids and acellular pertussis [whooping cough] (DtaP), measles, mumps, and rubella (MMR), varicella [chicken pox], and pneumococcal conjugate [pneumonia] vaccines; combined tetanus and diphtheria toxoids (Td) was also in short supply. Vaccine supply disruptions affected private practices and public clinics because both sectors purchase vaccines from the same manufacturers."

The Committee's report states that some of the problems that contributed to the shortage of vaccine supplies between 2000 and 2003 included a relatively low value given to preventive measures such as vaccines compared with that of therapeutic medicines, reflected in what individuals and public and private payers are willing to pay for vaccines; the high cost and complexity of development, approval, manufacturing and distribution of vaccines; the lack of continued investment in some vaccine manufacturing facilities; the relatively small number of vaccine manufacturers; and communication barriers between stakeholder groups, including proprietary information and confidentiality requirements that inhibit the recognition of evolving problems and development of effective responses.

The Committee concludes that: "Disruptions to the supply of routinely administered vaccines are likely to continue to occur. Action to implement short- and long-term solutions should be considered and implemented now."

The Committee recommends several solutions that may be implemented in the immediate future, including: increase funds for vaccine stockpiles; increase support for regulatory agencies; maintain and strengthen liability protections; require manufacturers to provide advance notice regarding intent to withdraw from marketplace; improve communications among leaders and consumers - provide accurate information about vaccine supply; initiate a national campaign to emphasize the safety and benefits of recommended vaccines for the public good.

Several strategies that require further study are: evaluation of appropriate financial incentives to manufacturers to sustain supply of existing vaccines and stimulate development of new vaccines; and streamline regulatory process without compromising safety or efficacy (JAMA. 2003;290:3122-3128. Available post-embargo at
Editor's Note: The source of funding for the stakeholder meeting was the Department of Health and Human Services (DHHS), which paid for travel and accommodations for all attendees as well as the meeting facility and transcription fees. The DHHS had no role in the protocol, development, data collection, and management. The DHHS assisted in manuscript preparation.

The JAMA Network Journals

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to